BridgeBio Oncology Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell BBOT and other ETFs, options, and stocks.About BBOT
Bridgebio Oncology Therapeutics, Inc. is a clinical-stage biopharmaceutical company. It focuses on advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3Ka malignancies.
BBOT Key Statistics
Stock Snapshot
BridgeBio Oncology Therapeutics(BBOT) stock is priced at $9.89, giving the company a market capitalization of 795.09M. It carries a P/E multiple of -10.96.
On 2026-03-05, BridgeBio Oncology Therapeutics(BBOT) stock traded between a low of $9.67 and a high of $10.17. Shares are currently priced at $9.89, which is +2.3% above the low and -2.8% below the high.
The BridgeBio Oncology Therapeutics(BBOT)'s current trading volume is 165.09K, compared to an average daily volume of 268.11K.
In the last year, BridgeBio Oncology Therapeutics(BBOT) shares hit a 52-week high of $14.87 and a 52-week low of $8.50.
In the last year, BridgeBio Oncology Therapeutics(BBOT) shares hit a 52-week high of $14.87 and a 52-week low of $8.50.
Analyst ratings
100%
of 9 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.